Virus therapy takes on Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial is testing a virus called IVX037, which is injected directly into tumours to kill cancer cells. It is being studied alone and combined with an immunotherapy drug (sintilimab) in people with advanced colorectal, gastric, or ovarian cancers that have stopped …
Phase: PHASE1 • Sponsor: ImmVirx Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC